Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
59,000
Employees59,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
59,000
Employees59,000

BSX Key Statistics

Market cap
73.24B
Market cap73.24B
Price-Earnings ratio
19.64
Price-Earnings ratio19.64
Dividend yield
Dividend yield
Average volume
24.34M
Average volume24.34M
High today
$50.16
High today$50.16
Low today
$48.60
Low today$48.60
Open price
$49.29
Open price$49.29
Volume
21.40M
Volume21.40M
52 Week high
$109.50
52 Week high$109.50
52 Week low
$42.20
52 Week low$42.20

Stock Snapshot

The current Boston Scientific(BSX) stock price is $49.11, with a market capitalization of 73.24B. The stock trades at a price-to-earnings (P/E) ratio of 19.64.

On 2026-08-06, Boston Scientific(BSX) stock traded between a low of $48.60 and a high of $50.16. Shares are currently priced at $49.11, which is +1.0% above the low and -2.1% below the high.

The Boston Scientific(BSX)'s current trading volume is 21.4M, compared to an average daily volume of 24.34M.

During the past year, Boston Scientific(BSX) stock moved between $42.20 at its lowest and $109.50 at its peak.

During the past year, Boston Scientific(BSX) stock moved between $42.20 at its lowest and $109.50 at its peak.

BSX News

Nasdaq 13h
September 25th Options Now Available For Boston Scientific

Investors in Boston Scientific Corp. (Symbol: BSX) saw new options become available today, for the September 25th expiration. At Stock Options Channel , our Yie...

September 25th Options Now Available For Boston Scientific
Zacks 14h
Boston Scientific's 2026 Guidance Cut Puts Its Recovery to the Test - Zacks Investment Research

...

Boston Scientific's 2026 Guidance Cut Puts Its Recovery to the Test - Zacks Investment Research
Simply Wall St 21h
Boston Scientific Recalls Hundreds Of Thousands Of Devices As FDA Flags Software Issue

Boston Scientific (NYSE:BSX) has initiated multiple large-scale recalls of cardiac ablation and access devices affecting hundreds of thousands of units globally...

Boston Scientific Recalls Hundreds Of Thousands Of Devices As FDA Flags Software Issue

Analyst ratings

85%

of 33 ratings
Buy
84.8%
Hold
15.2%
Sell
0%

More BSX News

Nasdaq 2d
Tuesday 8/4 Insider Buying Report: BSX, CMCO

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at tw...

Tuesday 8/4 Insider Buying Report: BSX, CMCO
TipRanks 2d
Boston Scientific’s Long-Term ESG Study: What Termination Means for Obesity Investment Sentiment

Boston Scientific (BSX) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confid...

TipRanks 3d
Boston Scientific Insider Makes Bold Move With Fresh Share Purchase

New insider activity at Boston Scientific ( (BSX) ) has taken place on August 3, 2026. Director Edward Ludwig has made a notable insider purchase of Boston Sci...

24/7 Wall St. 4d
Abbott Laboratories Lost 16% This Year: One Analyst Sees 35% Gains for the Healthcare Giant

Abbott Laboratories Lost 16% This Year: One Analyst Sees 35% Gains for the Healthcare Giant By Alex Sirois Published Aug 3, 11:44AM EDT Quick Read Barclays' M...

Abbott Laboratories Lost 16% This Year: One Analyst Sees 35% Gains for the Healthcare Giant
Simply Wall St 5d
Why Boston Scientific Is Up 5.6% After Mixed Q2, Recall News And Guidance Update

In late July 2026, Boston Scientific reported second-quarter results showing sales rising to US$5,442 million and net income reaching US$907 million, alongside...

Why Boston Scientific Is Up 5.6% After Mixed Q2, Recall News And Guidance Update
Simply Wall St 6d
Boston Scientific After Earnings Reset And Recall News Looks Undervalued

Boston Scientific (BSX) is back in focus after its 29 July 2026 earnings release, which included updated 2026 sales guidance and fresh detail on restructuring,...

Boston Scientific After Earnings Reset And Recall News Looks Undervalued

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.